The FDA granted 510(k) clearance to Medtronic's Aquamantys SBS 5.0 Sheathed Bipolar Sealer for spine surgery, according to a news release.
Medtronic acquired the technology last July when it purchased Salient Surgical Technologies for $480 million. Medtronic had participated in Salient's seven rounds of funding over the past 10 years. The surgical sealer uses "Transcollation" technology — a combination of radiofrequency energy and saline — and is designed for use with cut muscle tissue and with epidural veins.
Related Articles on Medical Devices:
MScore Technology Assesses Surgeon Competency With da Vinci Robot
FDA, Life Sciences Trade Group Partner to Improve Medical Device Review
Investment in Medical Device and Biotech Firms Hit 15-Year Low in 2011
Medtronic acquired the technology last July when it purchased Salient Surgical Technologies for $480 million. Medtronic had participated in Salient's seven rounds of funding over the past 10 years. The surgical sealer uses "Transcollation" technology — a combination of radiofrequency energy and saline — and is designed for use with cut muscle tissue and with epidural veins.
Related Articles on Medical Devices:
MScore Technology Assesses Surgeon Competency With da Vinci Robot
FDA, Life Sciences Trade Group Partner to Improve Medical Device Review
Investment in Medical Device and Biotech Firms Hit 15-Year Low in 2011